World's Best Scientists 2026 revealed!
George E. Peoples

George E. Peoples

D-Index & Metrics

Biology and Biochemistry

D-Index
53
Citations
8697
World Ranking
16309
National Ranking
6752

Overview

George E. Peoples is affiliated with LumaBridge in the United States, focusing on research primarily within medicine, immunology, and molecular biology. Their work extensively covers oncology, immunology, radiology, molecular biology, and biotechnology subfields.

Their research intersects multiple topics including immunotherapy and immune responses, monoclonal and polyclonal antibodies research, cancer immunotherapy and biomarkers, vaccines and immunoinformatics approaches, CAR-T cell therapy research, cancer research and treatments, and HER2/EGFR in cancer research.

Frequent co-authors collaborating with George E. Peoples include Guy T. Clifton, Timothy J. Vreeland, Robert C. Chick, Diane F. Hale, and Anne E. O'Shea.

Their publications have appeared notably in these venues:

  • Cancer Research
  • Journal of Clinical Oncology
  • Regular and Young Investigator Award Abstracts
  • Annals of Surgical Oncology
  • HPB

Recent papers authored or co-authored by George E. Peoples cover clinical trials and cancer immunotherapy, including:

  • Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer (2020, Clinical Cancer Research)
  • Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence (2020, Breast Cancer Research and Treatment)
  • Chemoprevention in familial adenomatous polyposis: past, present and future (2020, Familial Cancer)
  • Subgroup analysis of nelipepimut-S plus GM-CSF combined with trastuzumab versus trastuzumab alone to prevent recurrences in patients with high-risk, HER2 low-expressing breast cancer (2021, Clinical Immunology)
  • A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis (2021, Annals of Surgical Oncology)

Best Publications

  • T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells.

    Srully Blotnick;George E. Peoples;Michael R. Freeman;Timothy J. Eberlein

  • Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients

    Elizabeth Ann Mittendorf;G. T. Clifton;J. P. Holmes;E. Schneble

  • Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients

    George E. Peoples;Jennifer M. Gurney;Matthew T. Hueman;Mike M. Woll

  • Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

    George E. Peoples;George E. Peoples;Jarrod P. Holmes;Jarrod P. Holmes;Matthew T. Hueman;Matthew T. Hueman;Elizabeth A. Mittendorf

  • Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

    Elizabeth Ann Mittendorf;Guy T. Clifton;Jarrod P. Holmes;Kevin S. Clive

  • T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role.

    George E. Peoples;Srully Blotnick;Kazue Takahashi;Michael R. Freeman

  • Extracorporeal shock wave therapy suppresses the early proinflammatory immune response to a severe cutaneous burn injury.

    Thomas A Davis;Alexander Stojadinovic;Khairul Anam;Mihret Amare

  • Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial

    Elizabeth A. Mittendorf;Biao Lu;Michelle Melisko;Julie Price Hiller

  • The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02

    Linda C. Benavides;Jeremy D. Gates;Mark G. Carmichael;Ritesh Patel

  • Results of the First Phase I Clinical Trial of the Novel Ii-Key Hybrid Preventive HER-2/neu Peptide (AE37) Vaccine

    Jarrod P. Holmes;Linda C. Benavides;Jeremy D. Gates;Mark G. Carmichael

  • Trastuzumab Increases HER2 Uptake and Cross-Presentation by Dendritic Cells.

    Victor A Gall;Anne V Philips;Na Qiao;Karen Clise-Dwyer

  • The E75 HER2/ neu peptide vaccine

    Elizabeth A. Mittendorf;Jarrod P. Holmes;Jarrod P. Holmes;Sathibalan Ponniah;George E. Peoples;George E. Peoples

  • Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients: United States Military Cancer Institute Clinical Trials Group Study I-04.

    Mark G. Carmichael;Linda C. Benavides;Jarrod P. Holmes;Jeremy D. Gates

  • Investigating the Combination of Trastuzumab and HER2/neu Peptide Vaccines for the Treatment of Breast Cancer

    Elizabeth Ann Mittendorf;Catherine E. Storrer;Craig D. Shriver;Sathibalan Ponniah

  • Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex® technology

    Zia A. Dehqanzada;Catherine E. Storrer;Matthew T. Hueman;Rebecca J. Foley

  • Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.

    Alexander Stojadinovic;Aviram Nissan;Mladjan Protic;Carol F. Adair

  • Quality of life and cost effectiveness analysis of therapy for locally recurrent rectal cancer.

    Alexander R. Miller;Scott B. Cantor;George E. Peoples;David B. Pearlstone

  • Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence

    Elizabeth A. Mittendorf;Alexandros Ardavanis;Jennifer K. Litton;Nathan M. Shumway

  • Vaccine Implications of Folate Binding Protein, a Novel Cytotoxic T Lymphocyte-recognized Antigen System in Epithelial Cancers

    George E. Peoples;George E. Peoples;George E. Peoples;Brett W. Anderson;Tom V. Lee;James L. Murray

  • Primary Analysis of a Prospective, Randomized, Single-Blinded Phase II Trial Evaluating the HER2 Peptide AE37 Vaccine in Breast Cancer Patients to Prevent Recurrence

    E. A. Mittendorf;A. Ardavanis;J. Symanowski;J. L. Murray

Frequent Co-Authors

Elizabeth A. Mittendorf
Elizabeth A. Mittendorf Brigham and Women's Hospital
Alexander Stojadinovic
Alexander Stojadinovic Uniformed Services University of the Health Sciences
Michael Papamichail
Michael Papamichail St Savas Hospital
David G. McLeod
David G. McLeod Uniformed Services University of the Health Sciences
Constantin N. Baxevanis
Constantin N. Baxevanis St Savas Hospital
David M. Gershenson
David M. Gershenson The University of Texas MD Anderson Cancer Center
Kelly K. Hunt
Kelly K. Hunt The University of Texas MD Anderson Cancer Center
S. Eva Singletary
S. Eva Singletary The University of Texas MD Anderson Cancer Center
Judd W. Moul
Judd W. Moul Duke University
Henry Mark Kuerer
Henry Mark Kuerer The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're exploring majors like Biology or Biochemistry, a variety of online degree pathways can help tailor your education and career goals. Many students start with a biology degree online, enabling flexible study while building a foundation in the life sciences. This path is ideal for those considering lab work, research, or advanced degrees.

Healthcare roles continue to be in high demand. Pursuing online associate rn programs offers a fast and practical entry into nursing—making it possible to gain clinical skills and credentials while balancing work or family obligations.

Nutrition and wellness are also fast-growing fields. Those interested in dietetics or community health might consider online nutrition degrees, which blend biology, biochemistry, and applied health science into versatile career options.

If leadership in healthcare appeals to you, top cahme accredited mha programs prepare graduates for management roles within hospitals, public health organizations, and biotech companies. Combining advanced science knowledge with administrative skills can open up broader long-term career prospects.

Best Scientists Citing George E. Peoples

Trending Scientists

Recently Published Articles